J. C. Podjasek and R. S. Abraham, Autoimmune cytopenias in common variable immunodeficiency, Front Immunol, vol.3, p.189, 2012.

M. Krauth, J. Puthenparambil, and K. Lechner, Paraneoplastic autoimmune thrombocytopenia in solid tumors, Crit Rev Oncol Hematol, vol.81, pp.75-81, 2012.

D. M. Betsch, S. Gray, and S. E. Zed, A case of metastatic prostate cancer and immune thrombocytopenia, Curr Oncol, vol.24, pp.434-440, 2017.

E. J. Cho, H. J. Lee, K. U. Park, U. Kim, H. J. Lee et al., Immune thrombocytopenic purpura in a patient with renal cell carcinoma, Korean J Intern Med, vol.29, pp.671-675, 2014.

H. T. Ikizoglu, I. Ayan, F. Tokat, T. Tecimer, T. Tekant et al., Immune thrombocytopenia in a child with neuroblastoma. Case Rep Pediatr, p.1329489, 2017.

L. G. Rodríguez-lobato, N. Martinez-cibrian, F. Fernández-avilés, A. Gaya, E. Pineda-losada et al., Romiplostim for the treatment of glioblastoma-related paraneoplastic autoimmune thrombocytopenia refractory to conventional therapy, Ann Hematol, vol.95, pp.665-671, 2016.

T. Watanabe, Y. Matsumura, M. Minowa, H. Suzuki, H. Notsuda et al., Remission of newly diagnosed immune thrombocytopenia after lung cancer resection, Ann Thorac Surg, vol.97, pp.105-112, 2014.

V. Kiefel, S. Santoso, M. Weisheit, and C. Müeller-eckhardt, Monoclonal antibodyspecific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies, Blood, vol.70, pp.1722-1728, 1987.

Q. Zeng, L. Zhu, L. Tao, J. Bao, M. Yang et al., Relative efficacy of steroid therapy in immune thrombocytopenia mediated by antiplatelet GPIIbIIIa versus GPIb? antibodies, Am J Hematol, vol.87, pp.206-214, 2012.

D. M. Arnold, J. R. Vrbensky, N. Karim, J. W. Smith, Y. Liu et al., The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia, Br J Haematol, vol.178, pp.302-309, 2017.

J. Viallard, P. Blanco, M. André, E. G. Liferman, F. Neau et al., CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation, Clin Immunol, vol.119, pp.51-59, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00078052

S. Amisten, A rapid and efficient platelet purification protocol for platelet gene expression studies, Methods Mol Biol, vol.788, pp.155-72, 2012.

E. Henriet, A. Hammoud, A. Dupuy, J. Dartigues, B. Ezzoukry et al., Argininosuccinate synthase 1 (ASS1): a marker of unclassified hepatocellular adenoma and high bleeding risk, vol.66, pp.2016-2044, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01550711

M. Khellaf, M. Michel, A. Schaeffer, P. Bierling, and B. Godeau, Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count, Haematologica, vol.90, pp.829-861, 2005.

D. Provan, R. Stasi, A. C. Newland, V. S. Blanchette, P. Bolton-maggs et al., International consensus report on the investigation and management of primary immune thrombocytopenia, Blood, vol.115, pp.168-86, 2010.

M. Rojas, P. Restrepo-jiménez, D. M. Monsalve, Y. Pacheco, Y. Acosta-ampudia et al., Molecular mimicry and autoimmunity, J Autoimmun, vol.95, pp.100-123, 2018.

M. F. Cusick, J. E. Libbey, and R. S. Fujinami, Molecular mimicry as a mechanism of autoimmune disease, Clin Rev Allergy Immunol, vol.42, pp.102-113, 2012.

J. Ehser, M. Holdener, S. Christen, M. Bayer, J. M. Pfeilschifter et al., Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis, J Autoimmun, vol.42, pp.39-49, 2013.

C. Cornaby, L. Gibbons, V. Mayhew, C. S. Sloan, A. Welling et al., B cell epitope spreading: mechanisms and contribution to autoimmune diseases, Immunol Lett, vol.163, pp.56-68, 2015.

R. Stasi, N. Cooper, D. Poeta, G. Stipa, E. et al., Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab, Blood, vol.112, pp.1147-50, 2008.

J. Yu, S. Heck, V. Patel, J. Levan, Y. Yu et al., Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura, Blood, vol.112, pp.1325-1333, 2008.

B. Ghadaki, I. Nazi, J. G. Kelton, and D. M. Arnold, Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists, Transfusion, vol.53, pp.2807-2819, 2013.

M. Mahévas, O. Fain, M. Ebbo, F. Roudot-thoraval, N. Limal et al., The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study, Br J Haematol, vol.165, pp.865-874, 2014.

M. Swinkels, M. Rijkers, J. Voorberg, G. Vidarsson, F. Leebeek et al., Emerging concepts in immune thrombocytopenia, Front Immunol, vol.9, p.880, 2018.

C. Wang, Y. Shi, Y. Min, X. Zhu, C. Guo et al., Decreased IDO activity and increased TTS expression break immune tolerance in patients with immune thrombocytopenia, J Clin Immunol, vol.31, pp.643-652, 2011.

F. Rodeghiero, R. Stasi, T. Gernsheimer, M. Michel, D. Provan et al., Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group, Blood, vol.113, pp.2386-93, 2009.

C. Neunert, W. Lim, M. Crowther, A. Cohen, L. Solberg et al., The American society of hematology 2011 evidence-based practice guideline for immune thrombocytopenia, Blood, vol.117, pp.4190-207, 2011.